Nephrogenic Systemic Fibrosis Symptoms

Nephrogenic systemic fibrosis symptoms include one or more of the following:

  • burning and/or itchy skin
  • hardened, darkened, shiny skin
  • tight, sensitive skin that may be painful to the touch
  • loss of joint flexibility
  • joint pain (particularly deep pain in the hips or ribs)
  • impaired movement
  • muscle weakness
  • yellowed eyes

What is Nephrogenic Systemic Fibrosis?

Nephrogenic systemic fibrosis (NFS) is a rare, serious condition in which fibrous tissues develop within the connective tissues of the:

  • eyes
  • internal organs
  • joints
  • skin

Causes of Nephrogenic Systemic Fibrosis

Although medical experts are still researching the precise cause of nephrogenic systemic fibrosis, it is currently known that this disease is related to:

  • Exposure to certain MRI contrast dyes (These are substances that, when injected into the body before an MRI, will depict the structure and/or function of an organ on the resulting image.)
  • Use of immunosuppressant medications, such as those prescribed to treat psoriasis, hepatitis C and certain types of cancer

Nephrogenic systemic fibrosis, which does not have a genetic basis, may also be referred to as nephrogenic systemic dermopathy.

MRI Dyes Related to NSF

Some of the brand names of MRI contrast agents known to contribute to the development of nephrogenic systemic fibrosis include:

  • Magnevist
  • Multihance
  • Omniscan
  • OptiMARK.

The active agent in all of these MRI dyes (i.e. the component related to NSF) is gadolinium, a silvery-white metallic element. Known to be toxic, gadolinium side effects can include:

  • blood clots
  • headache
  • hypotension (significantly low blood pressure)
  • lightheadedness
  • nausea
  • NSF (This is the most serious gadolinium side effect known to date.)
  • severe allergic reaction (characterized by hives, breathing difficulties and facial inflammation)

To minimize the risk of developing gadolinium side effects, patients with kidney problems should not be administered gadolinium MRI contrast agents.

Following an NSF Diagnosis: Meeting with an Nephrogenic Systemic Fibrosis Attorney

As soon as an individual begins to show signs of nephrogenic systemic fibrosis symptoms they should seek immediate medical attention. Anyone diagnosed with nephrogenic systemic fibrosis should then:

  • Follow through with all prescribed treatments for the best chances of recovery
  • Meet with a personal injury lawyer who specializes in NSF lawsuits

An experienced attorney for NSF patients will thoroughly evaluate the details of the individual case and determine whether the patient has grounds for filing a claim. If the patient is eligible to file a NSF lawsuit, a qualified attorney will guide him or her through every step of the legal process, even trial if necessary.

Compensation for NSF Patients

By following through with a nephrogenic systemic fibrosis lawsuit, injured parties (including families of deceased NSF patients) can win compensation for their:

  • funeral and burial costs
  • past hospital bills
  • ongoing treatment costs
  • lost wages
  • future living costs
  • permanent disabilities
  • pain and suffering

What to do Following Nephrogenic Systemic Fibrosis Symptoms

If you or someone you love begins to show signs of nephrogenic systemic fibrosis symptoms you should seek medical attention immediately. Once your diagnosis is confirmed, contact a nephrogenic systemic fibrosis lawyer for legal help. We will help you recover the compensation you need to pay for necessary nephrogenic systemic fibrosis treatment programs and medication.

Enter Content Here

Gadolinium Contrast Agents Required to Include New Warning

The U.S. Food and Drug Administration (FDA) issued a news release Sept. 9, 2010, requiring that contrast agents containing gadolinium carry a new warning on their labels because it can lead to nephrogenic systemic fibrosis (NSF). Read More »

First Gadolinium Lawsuit Filed in U.S. Court

An Ohio woman has filed what is believed to be the first gadolinium lawsuit, claiming that the MRI dye Magnevist-made by Bayer-caused her 24-year-old son's death.
Read More »

Gadolinium-Based MRI Dyes Get Black Box Warning

The Food and Drug Administration has asked that a black box warning be added to all gadolinium-based MRI dyes to highlight the risk of nephrogenic systemic fibrosis, or NSF.
Read More »